浅析茵栀黄口服液联合间隙蓝光照射佐以双歧杆菌三联活菌治疗新生儿黄疸的疗效.docVIP

精品论文 参考文献 浅析茵栀黄口服液联合间隙蓝光照射佐以双歧杆菌三联活菌治疗新生儿黄疸的疗效 黑龙江省嫩江县伊拉哈镇中心卫生院 161437 　　摘要：目的 研究分析茵栀黄口服液联合间隙蓝光照射佐以双歧杆菌三联活菌治疗新生儿黄疸的临床效果。 方法 此次研究的对象是选择2012年3月～2015年3月我院收治的120例新生儿黄疸患儿。将其临床资料进行回顾性分析，并依据治疗措施不同进行分组，对照组40例给予常规治疗，联合治疗组80例给予茵栀黄口服液联合间隙蓝光照射佐以双歧杆菌三联活菌治疗。观察两组新生儿黄疸治疗前后经皮胆红素水平、治疗时间、临床疗效和不良反应发生率。 结果 治疗前对照组和联合治疗组患儿经皮胆红素水平[（312.3plusmn;50.4）、（309.8plusmn;48.4）mu;mol/L]与治疗后[（176.7plusmn;22.4）、（125.8plusmn;18.7）mu;mol/L]比较，差异均无统计学意义（P gt; 0.05）；治疗后两组患儿经皮胆红素均低于治疗前，治疗后联合治疗组低于对照组，差异均有统计学意义（P lt; 0.05）。联合治疗组患儿的日均胆红素下降值[（46.8plusmn;8.7）mu;mol/L]、治疗时间[（3.4plusmn;0.3）d]均优于对照组[（33.6plusmn;9.1）mu;mol/L、（5.0plusmn;1.0）d]，联合治疗组总有效率（100%）高于对照组（90%），总不良反应发生率（11.3%）低于对照组（45.0%），差异均有统计学意义（P lt; 0.05）。 结论 茵栀黄口服液联合间隙蓝光照射佐以双歧杆菌三联活菌可明显改善新生儿黄疸患儿的临床症状，疗效良好，值得临床推广应用。 　　关键词：茵栀黄口服液；间隙蓝光照射；双歧杆菌三联活菌；新生儿黄疸 　　[Abstract] Objective To study the clinical effect of Yinzhihuang oral liquid combined with blue light irradiation combined with clearance of Bifidobacterium triple viable in treatment of neonatal jaundice. Methods this study was to choose 120 cases of neonatal jaundice in our hospital from March 2015 to March 2012. The retrospective analysis of the clinical data, and according to different treatment groups, 40 patients in control group were given routine treatment, combined treatment group of 80 cases treated with Yinzhihuang oral liquid combined with blue light irradiation combined with clearance of Bifidobacterium triple viable treatment. Observation of the two groups of neonatal jaundice before and after treatment by percutaneous bilirubin level, treatment time, clinical efficacy and adverse reaction rate. Results before treatment, control group and treatment group with percutaneous bilirubin level [(312.3 + 50.4), (309.8 + 48.4) mol/L] after treatment with [(176.7 + 22.4), (125.8 + 18.7) mol/L], there were no significant differences (P gt; 0.05); the two groups after the treatment by skin bilirubin was lower than that before treatment, after treatment with the treatment group than the control group,